San Diego company’s test to detect pancreatic cancer in early stages moves to human trials

  • 📰 sdut
  • ⏱ Reading Time:
  • 28 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 95%

Business News News

Business Business Latest News,Business Business Headlines

Biological Dynamics spent more than a decade validating cancer diagnostic process spun out of UC San Diego and now has launched a study for people at high risk of pancreatic cancer

For more than a decade, Biological Dynamics has been working on technology licensed out of UC San Diego to enable early detection of diseases ranging from cancer to tuberculous to Alzheimer’s.

Founded in 2009, Biological Dynamics has developed proprietary technology that repels red blood cells and platelets to exclusively isolate exosomes — which are tiny structures inside a cell that contain some of the cell’s proteins, DNA and RNA. The lab-on-a-chip then detects the concentration of a handful of individual bio-markers specific to pancreatic cancer.

The company has raised $125 million since its founding to refine the technology. Biological Dynamics has 49 patents either granted or pending around its UCSD technology license.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 5. in BUSİNESS

Business Business Latest News, Business Business Headlines